Creative Medical Technology Holdings Inc

Creative Medical Technology Holdings Inc CELZ

Dividend Summary



There have not been any declared dividends recently.

Latest Dividends
Summary Previous dividend Next dividend
Status
Type
Per share
Declaration date
Ex-div date
Pay date

Enter the number of Creative Medical Technology Holdings Inc shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
We have not made any dividend predictions for Creative Medical Technology Holdings Inc
Dividend Yield Today
0.0%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for Creative Medical Technology Holdings Inc
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
There are no Creative Medical Technology Holdings Inc dividends.
Year Amount Change
2006 0.0c
2007 0.0c
0%
2008 0.0c
0%
2009 0.0c
0%
2010 0.0c
0%
2011 0.0c
0%
2012 0.0c
0%
2013 0.0c
0%
2014 0.0c
0%
2015 0.0c
0%
2016 0.0c
0%
2017 0.0c
0%
2018 0.0c
0%
2019 0.0c
0%
2020 0.0c
0%
2021 0.0c
0%
2022 Sign Up Required

Creative Medical Technology Holdings Inc Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
0.0%
Optimized Yield
Sign Up Required
52 Week High
0.0% on 19 January 2022
52 Week Low
0.0% on 19 January 2022
Next Ex-Div-Date Countdown
Sign Up Required

About Creative Medical Technology Holdings Inc

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company. The Company is focused on immunology, urology, neurology, and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. The Company conducts its commercial operations through its subsidiary, Creative Medical Technologies, Inc. (CMT). CMT markets and sells its CaverStem and FemCelz disposable kits utilized by physicians to perform autologous procedures that treat erectile dysfunction (ED) and female sexual dysfunction, respectively. Its products include CaverStem, FemCelz, StemSpine, ImmCelz and OvaStem. StemSpine is a regenerative stem cell procedure for the treatment of degenerative disc disease. ImmCelz is a universal donor stem cell therapy for stroke treatment. OvaStem is a stem cell therapy for premature ovarian failure. It is also focused on the use of its technologies covering treatments for various diseases.

Sector
Pharmaceuticals & Biotechnology
Country
United States
Share Price
$0.76 (yesterday's closing price)
Shares in Issue
7 million
Market Cap
$6mn
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
0
Market Indices
none
No articles found